Apollon Wealth Management, LLC Novo Nordisk A S Transaction History

Apollon Wealth Management, LLC

$4.22 Billion
Q4 2024

A detailed history of Apollon Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Apollon Wealth Management, LLC holds 44,228 shares of NVO stock, worth $3.95 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

44,228

Previous 38,835 13.89%

Holding current value

$3.95 Million

Previous $4.62 Million 17.73%

% of portfolio

0.09%

Previous 0.13%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	BUY	$85.0 - $120.04 $458,405 - $647,375	5,393 Added 13.89%	44,228 $3.8 Million
Q3 2024 Nov 04, 2024	BUY	$119.07 - $145.42 $107,877 - $131,750	906 Added 2.39%	38,835 $4.62 Million
Q2 2024 Jul 19, 2024	SELL	$122.71 - $146.91 $79,638 - $95,344	-649 Reduced 1.68%	37,929 $5.41 Million
Q1 2024 May 02, 2024	SELL	$102.11 - $135.92 $263,137 - $350,265	-2,577 Reduced 6.26%	38,578 $4.95 Million
Q4 2023 Feb 06, 2024	BUY	$87.78 - $105.45 $2.21 Million - $2.66 Million	25,179 Added 157.61%	41,155 $4.26 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $840,467 - $1.84 Million	9,242 Added 137.24%	15,976 $1.45 Million
Q2 2023 Aug 04, 2023	BUY	$155.98 - $172.65 $43,830 - $48,514	281 Added 4.35%	6,734 $1.09 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $37,452 - $45,036	-283 Reduced 4.2%	6,453 $1.03 Million
Q4 2022 Feb 15, 2023	SELL	$102.55 - $135.33 $17,433 - $23,006	-170 Reduced 2.46%	6,736 $911,000
Q3 2022 Nov 08, 2022	BUY	$95.28 - $116.93 $99,091 - $121,607	1,040 Added 17.73%	6,906 $688,000
Q2 2022 Aug 11, 2022	BUY	$103.24 - $121.81 $54,820 - $64,681	531 Added 9.95%	5,866 $654,000
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $150,077 - $181,414	1,612 Added 43.3%	5,335 $592,000
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $356,961 - $435,888	3,723 New	3,723 $417,000
Q1 2021 May 17, 2021	SELL	$67.06 - $75.82 $914,497 - $1.03 Million	-13,637 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$63.89 - $73.8 $871,267 - $1.01 Million	13,637 New	13,637 $953,000
Q3 2020 Nov 03, 2020	SELL	$63.69 - $70.22 $1,974 - $2,176	-31 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $1,814 - $2,106	31 New	31 $2,000

Others Institutions Holding NVO

# of Institutions

1,882

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $201B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apollon Wealth Management, LLC with notifications on news.

Account

Apollon Wealth Management, LLC Novo Nordisk A S Transaction History